Clinical Trials

Dr. McLaughlin's current clinical trials can be viewed by visiting Dr. McLaughlins Reseach website page. Here you will find more information including eligibilty requirements for each study.

The links below take you to the corresponding clinicaltrials.gov webpage.

Longitudinal Multi-omic Profiles to Reveal Mechanisms for Obesity-Mediated Insulin Resistance ("Metabolic Challenge")

Role of Nutrient Transit and Incretin Hormones in Hyperinsulinemic Hypoglycemia

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2 infection and inflammation in human adipose tissue

Improving Glycemic Control by Using a Virtual Weight Control Program and Continuous Glucose Monitoring

A double-blind randomized placebo-controlled dose-finding phase II study to assess the efficacy and safety of pasireotide s.c. in patients with Post-Bariatric Hypoglycemia

To enroll in these trials, contact:

Jasmine Yang
Assistant Clinical Research Coordinator, Medicine - Med/Endocrinology
jasminey@stanford.edu

Principle Investigator:

Dr. Tracey McLaughlin, MD, MS
Professor of Medicine

Type 2 Diabetes Weight Loss Research Study

To Join our Type 2 Diabetes Weight Loss Research Study, follow the QR Code above.